Bionano Genomics, Inc. (BNGO) vs Harvard Bioscience, Inc. (HBIO)
- Bionano Genomics, Inc. BNGO 1.25 −8.76%
- Harvard Bioscience, Inc. HBIO 8.09 −2.65%
Bionano Genomics, Inc. and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $37.8M against $16.1M — 2.3× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −1.06%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −106.6%) and the higher return on invested capital (−0.41% vs −81.7%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 9 and Harvard Bioscience, Inc. on 9.
Valuation
Profitability
| Metric | BNGO | HBIO | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 47.51% | 58.16% | 54.29% |
| Operating margin | (106.67%) | (0.28%) | 1.07% |
| Net margin | (106.58%) | (11.86%) | (1.61%) |
| Free cash flow margin | (67.87%) | (2.09%) | 1.08% |
| Return on equity | (83.56%) | (89.95%) | (1.32%) |
| Return on assets | (52.04%) | (13.32%) | 0.00% |
| Return on invested capital | (81.68%) | (0.41%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack